These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 31364594)
1. Rational combinations of immunotherapy with radiotherapy in ovarian cancer. Herrera FG; Irving M; Kandalaft LE; Coukos G Lancet Oncol; 2019 Aug; 20(8):e417-e433. PubMed ID: 31364594 [TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy for the treatment of head and neck cancer. Karam SD; Raben D Lancet Oncol; 2019 Aug; 20(8):e404-e416. PubMed ID: 31364593 [TBL] [Abstract][Full Text] [Related]
3. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. Deutsch E; Chargari C; Galluzzi L; Kroemer G Lancet Oncol; 2019 Aug; 20(8):e452-e463. PubMed ID: 31364597 [TBL] [Abstract][Full Text] [Related]
4. Epithelial ovarian cancer: the role of radiotherapy. Dembo AJ Int J Radiat Oncol Biol Phys; 1992; 22(5):835-45. PubMed ID: 1555974 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future. Naghavi AO; Johnstone PA; Kim S Curr Probl Cancer; 2016; 40(1):38-67. PubMed ID: 26656977 [TBL] [Abstract][Full Text] [Related]
7. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership. Chajon E; Castelli J; Marsiglia H; De Crevoisier R Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy and Radiation: Charting a Path Forward Together. Sridharan V; Schoenfeld JD Hematol Oncol Clin North Am; 2019 Dec; 33(6):1057-1069. PubMed ID: 31668206 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for ovarian cancer: recent advances and perspectives. Zsiros E; Tanyi J; Balint K; Kandalaft LE Curr Opin Oncol; 2014 Sep; 26(5):492-500. PubMed ID: 25036883 [TBL] [Abstract][Full Text] [Related]
10. Integration of radiation and immunotherapy in breast cancer - Treatment implications. Ye JC; Formenti SC Breast; 2018 Apr; 38():66-74. PubMed ID: 29253718 [TBL] [Abstract][Full Text] [Related]
11. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy. Shahabi V; Postow MA; Tuck D; Wolchok JD Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204 [TBL] [Abstract][Full Text] [Related]
14. Update on the role of radiotherapy in ovarian cancer. Lanciano R; Reddy S; Corn B; Randall M Semin Oncol; 1998 Jun; 25(3):361-71. PubMed ID: 9633849 [No Abstract] [Full Text] [Related]
15. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Baxevanis CN; Perez SA; Papamichail M Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409 [TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications. Esposito A; Criscitiello C; Curigliano G Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875 [TBL] [Abstract][Full Text] [Related]
17. Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy. Lee S; Son B; Park G; Kim H; Kang H; Jeon J; Youn H; Youn B Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227629 [TBL] [Abstract][Full Text] [Related]
18. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity? Wirsdörfer F; de Leve S; Jendrossek V Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577587 [TBL] [Abstract][Full Text] [Related]